Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
B
|
pubmed:dateCreated |
1978-12-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
215-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:357390-Bacterial Infections,
pubmed-meshheading:357390-Cefoxitin,
pubmed-meshheading:357390-Cephalosporins,
pubmed-meshheading:357390-Clinical Trials as Topic,
pubmed-meshheading:357390-Humans,
pubmed-meshheading:357390-Injections, Intramuscular,
pubmed-meshheading:357390-Injections, Intravenous
|
pubmed:year |
1978
|
pubmed:articleTitle |
Clinical experience with cefoxitin sodium in extensive trials.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|